528 related articles for article (PubMed ID: 32370863)
1. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
[TBL] [Abstract][Full Text] [Related]
2. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
[TBL] [Abstract][Full Text] [Related]
3. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Arch Toxicol; 2020 Jul; 94(7):2549-2557. PubMed ID: 32514609
[TBL] [Abstract][Full Text] [Related]
4. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
[TBL] [Abstract][Full Text] [Related]
5. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
J Toxicol Environ Health A; 2020 Jul; 83(13-14):485-494. PubMed ID: 32552445
[TBL] [Abstract][Full Text] [Related]
6. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Hengstler J; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Food Chem Toxicol; 2020 Aug; 142():111349. PubMed ID: 32360905
[TBL] [Abstract][Full Text] [Related]
7. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Toxicol Lett; 2020 Oct; 331():259-264. PubMed ID: 32360654
[No Abstract] [Full Text] [Related]
8. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers.
Dogan S; Simsek T
Med Hypotheses; 2016 Jul; 92():84-7. PubMed ID: 27241264
[TBL] [Abstract][Full Text] [Related]
9. Environmental exposures to endocrine disrupting chemicals (EDCs) and their role in endometriosis: a systematic literature review.
Sirohi D; Al Ramadhani R; Knibbs LD
Rev Environ Health; 2021 Mar; 36(1):101-115. PubMed ID: 32903210
[TBL] [Abstract][Full Text] [Related]
10. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
Yilmaz B; Terekeci H; Sandal S; Kelestimur F
Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
[TBL] [Abstract][Full Text] [Related]
11. Editorial on editorial: Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Toxicol In Vitro; 2020 Sep; 67():104862. PubMed ID: 32360642
[No Abstract] [Full Text] [Related]
12. Male pubertal development: are endocrine-disrupting compounds shifting the norms?
Zawatski W; Lee MM
J Endocrinol; 2013; 218(2):R1-12. PubMed ID: 23709001
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine and behavioral effects of embryonic exposure to endocrine disrupting chemicals in birds.
Ottinger MA; Lavoie E; Thompson N; Barton A; Whitehouse K; Barton M; Abdelnabi M; Quinn M; Panzica G; Viglietti-Panzica C
Brain Res Rev; 2008 Mar; 57(2):376-85. PubMed ID: 18006066
[TBL] [Abstract][Full Text] [Related]
14. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.
Wan MLY; Co VA; El-Nezami H
Crit Rev Food Sci Nutr; 2022; 62(24):6549-6576. PubMed ID: 33819127
[TBL] [Abstract][Full Text] [Related]
15. Exposure to environmental endocrine disrupting compounds and men's health.
Meeker JD
Maturitas; 2010 Jul; 66(3):236-41. PubMed ID: 20347536
[TBL] [Abstract][Full Text] [Related]
16. A restatement of the natural science evidence base on the effects of endocrine disrupting chemicals on wildlife.
Godfray HCJ; Stephens AEA; Jepson PD; Jobling S; Johnson AC; Matthiessen P; Sumpter JP; Tyler CR; McLean AR
Proc Biol Sci; 2019 Feb; 286(1897):20182416. PubMed ID: 30963852
[TBL] [Abstract][Full Text] [Related]
17. Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification.
La Merrill MA; Vandenberg LN; Smith MT; Goodson W; Browne P; Patisaul HB; Guyton KZ; Kortenkamp A; Cogliano VJ; Woodruff TJ; Rieswijk L; Sone H; Korach KS; Gore AC; Zeise L; Zoeller RT
Nat Rev Endocrinol; 2020 Jan; 16(1):45-57. PubMed ID: 31719706
[TBL] [Abstract][Full Text] [Related]
18. Endocrine Aspects of Environmental "Obesogen" Pollutants.
Nappi F; Barrea L; Di Somma C; Savanelli MC; Muscogiuri G; Orio F; Savastano S
Int J Environ Res Public Health; 2016 Jul; 13(8):. PubMed ID: 27483295
[TBL] [Abstract][Full Text] [Related]
19. DNA microarrays for detecting endocrine-disrupting compounds.
Francois E; Wang DY; Fulthorpe R; Liss SN; Edwards EA
Biotechnol Adv; 2003 Dec; 22(1-2):17-26. PubMed ID: 14623040
[TBL] [Abstract][Full Text] [Related]
20. Endocrine-disrupting chemicals: economic, regulatory, and policy implications.
Kassotis CD; Vandenberg LN; Demeneix BA; Porta M; Slama R; Trasande L
Lancet Diabetes Endocrinol; 2020 Aug; 8(8):719-730. PubMed ID: 32707119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
